Advertisement

January 12, 2021

Mermaid Medical Group Begins Full Market Launch of the D-Clot HD Rotational Thrombectomy System

January 12, 2021—Mermaid Medical Group, a Denmark-based company, announced the full commercial launch in the United States of the D-Clot HD rotational thrombectomy system for arteriovenous access flow restoration.Mermaid Medical D-Clot HD Rotational Thrombectomy System

According to the company, an evaluation of a multicenter limited-market release demonstrated the system’s ability to restore flow effectively and safely with no reported complications in 25 hemodialysis access thrombectomy patients. Mermaid noted that the data derive from several institutions where numerous users applied the technology to patients and showed effectiveness across variations in vessel size, access type, and thrombus morphology.

Advertisement


January 12, 2021

FDA Approves MicroVention’s Lower-Profile WEB 17 Intrasaccular Aneurysm Treatment Device

January 8, 2021

FDA Clears Inari Medical’s FlowTriever System for Treatment of Right Atrial Clot in Transit


)